Search Results - "Emanuelli, Andres"
-
1
Unilateral Cataract and Retinitis Pigmentosa in a Patient With Polyneuropathy, Hearing Loss, Ataxia, Retinitis Pigmentosa, and Cataract (PHARC) Syndrome: A Case Report
Published in Curēus (Palo Alto, CA) (16-02-2024)“…Patients with mutations in the α/β hydrolase gene develop ocular complications including cataracts and retinitis pigmentosa (RP), as part of the…”
Get full text
Journal Article -
2
Nd:YAG Laser Hyaloidotomy: A Therapeutic Approach for Valsalva Premacular Hemorrhage
Published in Curēus (Palo Alto, CA) (25-03-2024)“…Subhyaloid hemorrhage, characterized by localized vitreoretinal detachment due to blood accumulation, often results in sudden vision loss, especially in the…”
Get full text
Journal Article -
3
Structure-based virtual screening workflow to identify antivirals targeting HIV-1 capsid
Published in Journal of computer-aided molecular design (01-03-2022)“…We have identified novel HIV-1 capsid inhibitors targeting the PF74 binding site. Acting as the building block of the HIV-1 capsid core, the HIV-1 capsid…”
Get full text
Journal Article -
4
Potency and metabolic stability: a molecular hybrid case in the design of novel PF74-like small molecules targeting HIV-1 capsid protein
Published in RSC medicinal chemistry (15-12-2021)“…PF74 ( 1 ) is a potent and well-characterized prototypical small molecule targeting human immunodeficiency virus type 1 (HIV-1) capsid protein (CA), but not a…”
Get full text
Journal Article -
5
Expanding the phenotype of TTLL5-associated retinal dystrophy: a case series
Published in Orphanet journal of rare diseases (01-04-2022)“…Inherited retinal dystrophies describe a heterogeneous group of retinal diseases that lead to the irreversible degeneration of rod and cone photoreceptors and…”
Get full text
Journal Article -
6
Design, Synthesis and Characterization of HIV-1 CA-Targeting Small Molecules: Conformational Restriction of PF74
Published in Viruses (15-03-2021)“…Small molecules targeting the PF74 binding site of the HIV-1 capsid protein (CA) confer potent and mechanistically unique antiviral activities. Structural…”
Get full text
Journal Article -
7
Evaluation of cardiac parameters and other safety outcomes of brolucizumab treatment in patients with neovascular age‐related macular degeneration
Published in Pharmacology research & perspectives (01-04-2022)“…This was a prospective, single‐dose, single‐arm, open‐label, non‐randomized, multicenter clinical study to determine cardiovascular safety after a single…”
Get full text
Journal Article -
8
Reactivation of Acute Retinal Necrosis following SARS-CoV-2 Infection
Published in Case reports in ophthalmological medicine (16-07-2021)“…Purpose. To report on a case of reactivation of acute retinal necrosis following SARS-CoV-2 infection. Methods. Observational case report. Observations. A…”
Get full text
Journal Article -
9
Optical coherence tomography angiography findings in macular toxoplasma retinochoroiditis: A case report
Published in American journal of ophthalmology case reports (01-09-2020)“…To report the optical coherence tomography angiography (OCT-A) findings in a patient with macular toxoplasma retinochoroiditis (TRC). A 14-year old female…”
Get full text
Journal Article -
10
KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema
Published in American journal of ophthalmology (01-06-2022)“…To compare the efficacy and safety of brolucizumab with aflibercept in patients with diabetic macular edema (DME). Double-masked, 100-week, multicenter,…”
Get full text
Journal Article -
11
Unilateral choroidal neovascular membrane as a herald lesion for Crohn's disease
Published in Ophthalmic surgery, lasers & imaging retina (01-01-2014)“…Crohn's disease is a diffuse inflammatory disease primarily affecting the gastrointestinal tract but with associated ophthalmologic complications that often…”
Get more information
Journal Article -
12
Efficacy and Safety of Brolucizumab for Diabetic Macular Edema: The KINGFISHER Randomized Clinical Trial
Published in JAMA ophthalmology (01-12-2023)“…Despite the effectiveness of existing anti-vascular endothelial growth factor (VEGF) therapies, a need remains for further treatment options to improve…”
Get more information
Journal Article -
13
Genetic analysis of patients with nonsyndromic and syndromic retinitis pigmentosa in Puerto Rico: a genetic legacy
Published in Ophthalmic genetics (01-08-2022)“…BACKGROUNDRetinitis pigmentosa (RP) is a genetically heterogeneous group of diseases characterized by complete progressive vision loss; it has a prevalence of…”
Get full text
Journal Article -
14
Management of 2 intraocular lenses in the same eye
Published in JAMA ophthalmology (01-01-2013)“…To present options for managing a patient with a dislocated intraocular lens (IOL) in the presence of a second, nondislocated IOL. A review of 3 consecutive…”
Get more information
Journal Article -
15
Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial
Published in JAMA ophthalmology (01-09-2021)“…Proactive treatment of nonproliferative diabetic retinopathy (NPDR) reduces the risk of progression to vision-threatening complications. To evaluate vascular…”
Get more information
Journal Article -
16
Characteristics Upon Presentation of Patients with Type 2 Macular Telangiectasia in Puerto Rico
Published in Puerto Rico health sciences journal (01-03-2022)“…To describe the systemic disease associations and clinical features upon initial presentation of a cohort of patients with type 2 macular telangiectasia who…”
Get full text
Journal Article -
17
Retinitis Pigmentosa Associated With EYS Gene Mutations in Puerto Rico: A Case Series
Published in Curēus (Palo Alto, CA) (26-10-2024)Get full text
Journal Article -
18
Efficacy and Safety of Intraoperative Mitomycin C as Adjunct Therapy for Pterygium Surgery
Published in Cornea (01-12-2008)“…PURPOSES:The primary objective of this study was to determine if intraoperative application of mitomycin C (MMC) is safe as an adjunct for pterygium surgery…”
Get full text
Journal Article -
19
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial
Published in The Lancet (British edition) (23-03-2024)“…A high-dose formulation of intravitreal aflibercept (8 mg) could improve treatment outcomes in diabetic macular oedema (DMO) by requiring fewer injections than…”
Get full text
Journal Article -
20
Low-dose methotrexate for the treatment of chronic central serous chorioretinopathy: a retrospective analysis
Published in Retina (Philadelphia, Pa.) (01-11-2012)“…To evaluate the utility of oral methotrexate (MTX) for the treatment of chronic central serous chorioretinopathy (CSCR). Retrospective review of all eyes of…”
Get full text
Journal Article